Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Net Sales
54.10
31.41
Other Operating Income
0.00
0.00
Total Operating income
54.10
31.41
Raw Material Cost
23.53
14.83
Purchase of Finished goods
1.65
0.01
(Increase) / Decrease In Stocks
-0.79
1.27
Employee Cost
3.48
2.62
Power Cost
0.00
0.00
Manufacturing Expenses
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
Other Expenses
7.02
2.95
Total Expenditure (Excl Depreciation)
34.89
21.68
Operating Profit (PBDIT) excl Other Income
19.21
9.73
Other Income
0.41
0.10
Operating Profit (PBDIT)
19.62
9.83
Interest
1.82
1.45
Exceptional Items
0.00
0.00
Gross Profit (PBDT)
17.80
8.38
Depreciation
0.41
0.36
Profit Before Tax
17.38
8.01
Tax
4.36
1.98
Provisions and contingencies
0.00
0.00
Profit After Tax
13.02
6.03
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
13.02
6.03
Share in Profit of Associates
0.00
0.00
Minority Interest
-0.16
-0.33
Other related items
0.00
0.00
Consolidated Net Profit
12.86
5.70
Equity Capital
18.09
8.86
Face Value
10.0
10.0
Reserves
0.00
0.00
Earnings per share (EPS)
7.11
6.43
Diluted Earnings per share
9.12
6.16
Operating Profit Margin (Excl OI)
35.51%
30.98%
Gross Profit Margin
32.9%
26.68%
PAT Margin
24.07%
19.2%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2025 is 90.83%
Standalone Net Profit
Growth in half year ended Sep 2025 is 306.74%
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2025 is 216.01%
Interest
Growth in half year ended Sep 2025 is 24.83%
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2025 has improved from Sep 2024
Compare Half Yearly Results Of Anondita Medi. With
Figures in Cr
Consolidate Half Yearly Results
Change(INR)
Change(%)
Net Sales
54.10
3,277.95
-3,223.85
-98.35%
Other Operating Income
0.00
0.00
0.00
Total Operating income
54.10
3,277.95
-3,223.85
-98.35%
Raw Material Cost
23.53
2,686.07
-2,662.54
-99.12%
Purchase of Finished goods
1.65
0.00
1.65
(Increase) / Decrease In Stocks
-0.79
246.69
-247.48
-100.32%
Employee Cost
3.48
67.23
-63.75
-94.82%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
7.02
177.20
-170.18
-96.04%
Total Expenditure (Excl Depreciation)
34.89
3,177.19
-3,142.30
-98.90%
Operating Profit (PBDIT) excl Other Income
19.21
100.76
-81.55
-80.93%
Other Income
0.41
47.43
-47.02
-99.14%
Operating Profit (PBDIT)
19.62
148.19
-128.57
-86.76%
Interest
1.82
14.14
-12.32
-87.13%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
17.80
134.05
-116.25
-86.72%
Depreciation
0.41
15.61
-15.20
-97.37%
Profit Before Tax
17.38
118.44
-101.06
-85.33%
Tax
4.36
28.05
-23.69
-84.46%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
13.02
90.39
-77.37
-85.60%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
13.02
90.39
-77.37
-85.60%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
-0.16
0.18
-0.34
-188.89%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
12.86
90.56
-77.70
-85.80%
Equity Capital
18.09
50.08
-31.99
-63.88%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
7.11
1.81
5.30
292.82%
Diluted Earnings per share
9.12
1.81
7.31
403.87%
Operating Profit Margin (Excl OI)
35.51%
3.07%
0.00
32.44%
Gross Profit Margin
32.90%
4.09%
0.00
28.81%
PAT Margin
24.07%
2.76%
0.00
21.31%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 47.65 Cr
in Sep 2025Figures in Cr
Half Yearly - Standalone Net Profit
Standalone Net Profit 11.47 Cr
in Sep 2025Figures in Cr
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16.78 Cr
in Sep 2025Figures in Cr
Half Yearly - Interest
Interest 1.81 Cr
in Sep 2025Figures in Cr
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 35.22%
in Sep 2025Figures in %






